Cargando…
Meta-analysis and systematic literature review of COVID-19 associated bradycardia as a predictor of mortality
BACKGROUND: Cardiac arrhythmias have been identified as independent predictors of mortality in Coronavirus disease 2019 (COVID-19) patients. While some studies have reported poor prognosis with bradycardia in COVID-19 patients, others have not found any association between bradycardia and mortality...
Autores principales: | Umeh, Chukwuemeka A., Kumar, Sabina, Wassel, Elias, Barve, Pranav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166215/ https://www.ncbi.nlm.nih.gov/pubmed/35665869 http://dx.doi.org/10.1186/s43044-022-00284-8 |
Ejemplares similares
-
A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients
por: Umeh, Chukwuemeka, et al.
Publicado: (2022) -
A novel study on SARS‐COV‐2 virus associated bradycardia as a predictor of mortality‐retrospective multicenter analysis
por: Kumar, Sabina, et al.
Publicado: (2021) -
Response to Dr. Masaya Miyauchi and Dr. Teruhiko Imamura, Clinical implication of COVID‐19 associated bradycardia
por: Kumar, Sabina, et al.
Publicado: (2021) -
Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation
por: Umeh, Chukwuemeka A, et al.
Publicado: (2023) -
Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)